1. Home
  2. DCTH vs BRDG Comparison

DCTH vs BRDG Comparison

Compare DCTH & BRDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • BRDG
  • Stock Information
  • Founded
  • DCTH 1988
  • BRDG 2009
  • Country
  • DCTH United States
  • BRDG United States
  • Employees
  • DCTH N/A
  • BRDG N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • BRDG Investment Managers
  • Sector
  • DCTH Health Care
  • BRDG Finance
  • Exchange
  • DCTH Nasdaq
  • BRDG Nasdaq
  • Market Cap
  • DCTH 398.2M
  • BRDG 348.5M
  • IPO Year
  • DCTH N/A
  • BRDG 2021
  • Fundamental
  • Price
  • DCTH $14.31
  • BRDG $7.87
  • Analyst Decision
  • DCTH Strong Buy
  • BRDG Buy
  • Analyst Count
  • DCTH 4
  • BRDG 7
  • Target Price
  • DCTH $22.25
  • BRDG $10.21
  • AVG Volume (30 Days)
  • DCTH 411.6K
  • BRDG 216.4K
  • Earning Date
  • DCTH 11-08-2024
  • BRDG 02-19-2025
  • Dividend Yield
  • DCTH N/A
  • BRDG 5.34%
  • EPS Growth
  • DCTH N/A
  • BRDG N/A
  • EPS
  • DCTH N/A
  • BRDG 0.09
  • Revenue
  • DCTH $22,644,000.00
  • BRDG $404,932,000.00
  • Revenue This Year
  • DCTH $1,605.13
  • BRDG $29.38
  • Revenue Next Year
  • DCTH $111.67
  • BRDG $25.41
  • P/E Ratio
  • DCTH N/A
  • BRDG $90.92
  • Revenue Growth
  • DCTH 945.91
  • BRDG 63.66
  • 52 Week Low
  • DCTH $3.70
  • BRDG $6.18
  • 52 Week High
  • DCTH $14.47
  • BRDG $11.69
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 70.27
  • BRDG 40.47
  • Support Level
  • DCTH $12.14
  • BRDG $7.92
  • Resistance Level
  • DCTH $12.98
  • BRDG $8.41
  • Average True Range (ATR)
  • DCTH 0.77
  • BRDG 0.30
  • MACD
  • DCTH 0.16
  • BRDG 0.02
  • Stochastic Oscillator
  • DCTH 95.12
  • BRDG 51.37

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

About BRDG Bridge Investment Group Holdings Inc.

Bridge Investment Group Holdings Inc is a vertically integrated investment manager, diversified across specialized asset classes. The company combines its nationwide operating platform with dedicated teams of investment professionals focused on various specialized and synergistic investment platforms, including real estate, credit, renewable energy, and secondaries strategies. Its broad range of products and vertically integrated structure allow it to capture new market opportunities and serve investors with various investment objectives. The company operates Its business in a single segment, alternative investment management, diversified across specialized and synergistic investment platforms.

Share on Social Networks: